Pvg Asset Management Corp Vascular Biogenics Ltd. Transaction History

Pvg Asset Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	SELL	$0.15 - $2.1 $1,854 - $25,966	-12,365 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$1.94 - $2.55 $407 - $535	210 Added 1.73%	12,365 $25,000
Q2 2021 Aug 17, 2021	SELL	$1.69 - $2.67 $24,555 - $38,795	-14,530 Reduced 54.45%	12,155 $29,000
Q1 2021 May 14, 2021	SELL	$1.79 - $2.91 $58,216 - $94,641	-32,523 Reduced 54.93%	26,685 $53,000
Q1 2020 May 15, 2020	BUY	$0.96 - $1.57 $18,410 - $30,109	19,178 Added 47.91%	59,208 $79,000
Q4 2019 Feb 26, 2020	BUY	$1.1 - $1.32 $44,033 - $52,839	40,030 New	40,030 $48,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Pvg Asset Management Corp with notifications on news.